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Rigidly connected multispecific 
artificial binders with adjustable 
geometries
Yufan Wu1,2, Alexander Batyuk1,3, Annemarie Honegger  1, Fabian Brandl1, Peer R. E. Mittl1 
& Andreas Plückthun  1
Multivalent binding proteins can gain biological activities beyond what is inherent in the individual 
binders, by bringing together different target molecules, restricting their conformational flexibility 
or changing their subcellular localization. In this study, we demonstrate a method to build up rigid 
multivalent and multispecific scaffolds by exploiting the modular nature of a repeat protein scaffold 
and avoiding flexible linkers. We use DARPins (Designed Ankyrin Repeat Proteins), synthetic binding 
proteins based on the Ankyrin-repeat protein scaffold, as binding units. Their ease of in vitro selection, 
high production yield and stability make them ideal specificity-conferring building blocks for the design 
of more complex constructs. C- and N-terminal DARPin capping repeats were re-designed to be joined 
by a shared helix in such a way that rigid connector modules are formed. This allows us to join two or 
more DARPins in predefined geometries without compromising their binding affinities and specificities. 
Nine connector modules with distinct geometries were designed; for eight of these we were able 
to confirm the structure by X-ray crystallography, while only one did not crystallize. The bispecific 
constructs were all able to bind both target proteins simultaneously.
In the past decade, protein binders based on various scaffolds and selected by display methods from gene librar-
ies randomized in specific positions have been developed as an alternative to monoclonal antibody technol-
ogy. Different scaffolds offer specific advantages and disadvantages1: natural and fully synthetic antibody Fab 
(~50 kDa) and single-chain (scFv ~25 kDa) libraries mimic the diversity of natural antibody repertoires and 
yield binding modules similar to those generated by cloning of Fab or scFv fragments from specific monoclo-
nal antibodies. Nanobodies (~12 kDa) mimic camelid VHH domains and shark NAR variable domains, and are 
either derived from natural repertoires or from synthetic libraries based on humanized frameworks. Adnectins 
(~10 kDa) are based on the fibronectin type III domain scaffold, anticalins (~20 kDa) on the lipocalin structure, 
fynomers (~7.5 kDa) are derived from SH3 domains, affibodies (~7 kDa) are a three-helix bundle derived from 
a domain of protein A, knottins (~3–4 kDa) utilize a cysteine knot (for a recent review of alternative scaffolds in 
therapeutic use or development, see ref. 2).
Designed ankyrin repeat proteins (DARPins) represent a class of small, highly stable artificial binding proteins 
based on a repeat protein scaffold3–5, which have been developed for biochemical research, diagnostics and clini-
cal use (reviewed in ref. 6). They can be produced with high yields in E. coli, as they fold efficiently and do not rely 
on disulfide bridges for stability. Tightly packed repeats form a continuous hydrophobic core that is shielded from 
the solvent by specialized N- and C-terminal capping repeats (N-cap and C-cap). In DARPin libraries, six posi-
tions of each 33-amino-acid internal repeat are randomized. In selected binders, their surface forms a continuous 
paratope, stretching over typically two (termed N2C, ~15 kDa) to three (N3C, ~18 kDa) internal repeats. DARPin 
stability increases with increasing number of repeats: the melting temperature of the non-randomized DARPin 
scaffold increases from 60 °C for N1C (one internal repeat), 90 °C for N2C (two internal repeats) to >100 °C for 
N3C (three internal repeats) and larger DARPins. The midpoint of guanidinium hydrochloride denaturation 
changes from 1.4 M (N1C), 4.1 M (N2C), 5.6 M (N3C), to >8 M (N4C) and even higher for even larger scaffolds7. 
Unfolding of the C-terminal capping repeat at lower temperatures or guanidinium concentrations in the original 
1Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, CH-8057, Zürich, Switzerland. 2Present 
address: Paul Scherrer Institute, OFLC/106, 5232, Villigen PSI, Switzerland. 3Present address: Linac Coherent Light 
Source, SLAC National Accelerator Laboratory, 2575, Sand Hill Road, Menlo Park, CA, 94025, USA. Yufan Wu, 
Alexander Batyuk and Annemarie Honegger contributed equally to this work. Correspondence and requests for 
materials should be addressed to A.P. (email: plueckthun@bioc.uzh.ch)
Received: 30 May 2017
Accepted: 24 August 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 11217  | DOI:10.1038/s41598-017-11472-x
design was abolished by the introduction of stabilizing mutations in the C-cap8. A consequence of this molecular 
architecture, forming the basis of the present study, is the fact that the DARPin can be rigidly extended on either 
end. Various selection methods such as ribosome display5, phage display9 and yeast surface display10 have been 
used to select high-affinity binders from DARPin libraries.
A high-throughput technology has been developed that allows to select binders against 96 targets in parallel, 
usually yielding a diverse set of binders against several distinct epitopes on each target. From such a set, multiva-
lent binding proteins can be constructed to achieve biological activities beyond what is inherent in the individual 
binders, especially if their relative orientation can be controlled. These and many other applications demonstrate 
the urgent need for efficient structural characterization of DARPin complexes as a basis for understanding their 
mechanism of action and/or further improving the activity: e.g., DARPins have been engineered to work as intra-
cellular kinase sensors11, modulated the biological activities of a caspase12, served as starting points for engineer-
ing constructs active in vivo from biologically inactive individual domains (e.g. HER2-binders13, 14), or have been 
combined into retargeting adaptors for gene transfer vectors (Adenovirus knob clamp15).
In a recent study, we have shown that other protein domains starting with an α-helix can be rigidly fused to 
the C-terminal helix of the capping repeat of a DARPin by forming a shared helix that is embedded along its entire 
length in at least one of the two domains. The relative orientation of the DARPin and its fusion partner depends 
on the length of the shared helix, giving rise to a whole series of constructs with different molecular geometries. 
Due to the modular nature of the DARPin structure, these modified capping repeats can be transferred between 
different binders without disturbing their binding affinity, as long as the capping repeat itself is not involved in 
binding. To prove this concept, we had previously designed a series of DARPin-β-lactamase fusions16, to be used 
as DARPin-based crystallization chaperones that exploit the β-lactamase to provide essential crystal contacts and 
explore molecular geometry as a screening dimension in crystallization trials.
In the current study, we present an extension to this approach: since DARPins start and end with α-helices, 
two or more DARPins can be joined in a similar manner. They can thus bring together two or more different 
target molecules in a supramolecular complex of predefined geometry, or can extend the footprint of a selected 
DARPin on its target to block adjacent interaction sites and can thus serve as a conformational sensor. We gen-
erated a series of nine connector modules that rigidly join two DARPins in different, well-defined orientations 
without obstructing the paratopes to test the validity of this design approach. We succeeded in crystallizing most 
of the two-DARPin and some of the three-DARPin scaffolds in the absence of target proteins to confirm their 
geometry, and additionally determined structures of some complexes, confirming the concept.
This rigid DARPin-DARPin fusion strategy also gives us another dimension in crystallization screening: 
Each DARPin can have different fusion and interaction partners, and each fusion partner can in turn have sev-
eral different fusion geometries, thereby providing an entire new screening dimension in crystallization trials. 
Furthermore, this fusion strategy is strengthened by the fortuitous discovery of a particular DARPin paratope 
that forms strong homophilic crystal contacts in several different relative orientations. We show here that this 
unliganded DARPin (termed D12) can be used in conjunction with any DARPin:target complex to facilitate its 
crystallization, using the rigid connector modules.
Throughout the manuscript, we apply the following nomenclature: DD and DDD represent constructs with 
two and three DARPin domains, respectively. DD constructs are named aaa_Hxx_bbb, where aaa and bbb are the 
abbreviated names of the N- and C-terminal DARPin domains and Hxx indicates shared helix (with xx ranging 
from 02 to 15). DDD constructs are named aaa_Hxx_bbb_Hyy_ccc using the same scheme. In case of complexes, 
the ligand name (e.g., Maltose-Binding Protein (MBP) or Green Fluorescent Protein (GFP)) is inserted right after 
the name of the cognate DARPin domain, and a colon separates the DARPin domain from its ligand.
Results
Design of rigid DARPin-DARPin fusions. The relative spatial orientation of the paratopes recognizing 
the ligands of a multivalent or bispecific DD construct is key for its functionality. In our constructs, the rigid helix 
connector between the DARPin domains determines the angle and distance between the DARPins, controlling 
the relative spatial orientation of the paratopes. Rigid shared helix connectors were designed using a multi-step 
procedure: (i) An idealized poly-alanine helix was superimposed on the C-terminal helix of the first DARPin 
(residues 161–168 for an N3C DARPin containing three internal repeats). (ii) The N-terminal helix of a second 
DARPin (residues 15–22) was superimposed onto a sliding 8-amino acid segment of that idealized poly-alanine 
helix (Fig. 1a). The raw models were screened for backbone-backbone clashes (Supplementary Fig. 1), and clash-
ing models were eliminated. (iii) The sequence of the shared helix was designed such that residues interacting 
with the DARPin cores were maintained. Rosetta fixbb17 was then used to optimize the sequence of the connect-
ing module, restricting sequence changes to positions within the original capping repeats (residues 136–197) 
and the shared helix and to substitutions that made a significant contribution to the total energy of the construct 
(Fig. 1c). (iv) To facilitate the exchange of DARPin specificities, unique restriction sites were placed at the bound-
aries between the specificity-determining internal repeats of the DARPins and the rigid shared helix connector 
modules (Fig. 1b).
This process yielded nine non-clashing constructs with shared helix lengths between 14 and 27 amino acids 
(DD constructs H02, H06, H09, H10, H11, H12, H13, H14, H15). Different lengths of the shared helix result in 
different relative domain orientations. These were quantified by a pseudo-torsion angle, which defines the helix as 
the axis and the two centers of gravity of the DARPin domains (themselves calculated from the Cα atoms of the 
three internal repeats) (Fig. 2). While constructs with longer shared helices are possible, we restricted the upper 
helix length to 27 residues, since the probability of local helix unfolding and/or bending increases with helix 
length. DDD models, containing three DARPins, were generated by superimposing the Cα atoms of the internal 
repeats of the second DARPin in one DD construct onto the internal repeats of the first DARPin in a second DD 
construct, generating a total of 81 possible DDD geometries.
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Superposition of the DARPin off7:MBP complex (Protein Data Bank (PDB) ID: 1SVX5) onto each of the 
DARPins in all constructs showed that in all DD constructs, all paratopes should be able to bind MBP-sized lig-
ands simultaneously without clashing. The same is true for 76 out of 81 DDD constructs. In five constructs (with 
the helix combinations H11/H10, H11/H14, H12/H06, H15/H10 and H15/H14), MBP binding to the first and 
third paratope would clash with each other (data not shown). The size of proteins which can be bound simulta-
neously to the different paratopes within a multivalent construct depends not so much on the distance between 
the paratopes than on their relative spatial orientation (for illustration, see Supplementary Fig. 2 for models of the 
nine symmetric DDD constructs with MBP bound to all three DARPin units).
Expression and Characterization. All DD and DDD constructs used for crystallization trials, carrying 
DARPins with different specificities, were expressed as soluble proteins in the cytoplasm of E. coli XL1-Blue and 
purified by immobilized metal ion affinity chromatography (IMAC). Each construct yielded 20 to 30 mg of pure 
protein per liter from non-optimized shake flask cultures. All DD constructs tested were found to retain bind-
ing to the respective targets, as analyzed by ELISA (Supplementary Fig. 3a), with signals similar to those of the 
Figure 1. Design of rigid DARPin-DARPin fusions. (a) Rigid fusions of two or more DARPins can be 
generated by joining the C-terminal helix of one DARPin to the N-terminal helix of a second DARPin. The 
length of the shared helix should optimally be less than the sum of the lengths of the individual helices, ensuring 
that the helix is embedded in at least one of the two domains along its entire length. The overall geometry of 
the construct depends on the length of the shared helix. Since the C-and the N-terminal helix of a DARPin run 
roughly antiparallel to each other, this results in the two paratopes facing in opposite directions, minimizing the 
probability of target proteins bound to the two paratopes clashing with each other. Capping repeats are shown 
in white, the terminal helices giving rise to the shared helix in pink, the internal repeats carrying the DARPin 
paratope in yellow. Residues randomized in the DARPin library, giving rise to the paratope in selected binders, 
are highlighted in orange. (b) Genetic organization of the constructs. The binding specificity of each DARPin 
is encoded in the sequence of its internal repeats (I1 to I3, etc.). The number of internal repeats can vary, 
three being most common. A non-randomized spacer repeat can be inserted between the randomized repeats 
and the connector module to adjust the spacing between the two paratopes and to avoid loss of affinity if the 
paratope of a selected binder extends onto the capping repeat. To facilitate the exchange of DARPin specificities, 
unique restriction sites were introduced between internal repeats and connector modules. (c) Sequences of 
the connector modules joining two DARPins. Residues retained from the original capping repeats (taken from 
a consensus DARPin with stabilized C-cap, mut5, PDB ID: 2XEE22) are shown in white and pink, residues 
changed by Rosetta fixbb17 sequence optimization are highlighted in red.
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monovalent DARPins, included as controls. Size exclusion chromatography (SEC) in the absence and presence of 
target molecules was used to confirm the stability of the ternary complexes and to determine the oligomeric states 
of the DD fusion constructs and their complexes with the cognate targets, e.g. MBP (42 kDa) and GFP (35 kDa). 
All DD constructs were monomeric at a concentration of 10 µM on analytical SEC (data not shown). The DD 
constructs bound their respective targets, as indicated by a shift of the preparative SEC peak from the elution vol-
ume of the unliganded DD constructs to that expected for the molecular weight of the complex (Supplementary 
Fig. 3b). All 9 off7_Hxx_3G124 constructs were able to bind MBP and GFP simultaneously, demonstrating the 
absence of steric hindrance between the two targets, consistent with the structural models.
Crystal structures of unliganded DD and DDD constructs. To validate the design, we first deter-
mined the crystal structures of the constructs. In this study, we present the structures of a total of fourteen 
DARPin-DARPin (DD) and DARPin-DARPin-DARPin (DDD) constructs, two of them as complexes with their 
target proteins. The structures represent eight out of nine different shared helix designs. To facilitate crystalli-
zation of the unliganded constructs, we used the internal repeats of DARPin D12. This DARPin was originally 
selected to recognize the V3 loop of human immunodeficiency virus envelope glycoprotein gp12018. In the con-
text of DARPin-β-lactamase fusions16, we observed that the paratope of this DARPin has a high propensity to 
form major crystal contacts, leading to crystal formation under a wide variety of conditions. Indeed, constructs 
D12_Hxx_D12 with H02, H09, H11, H13 and H15 yielded diffraction-quality crystals in space groups P212121, 
P6122, P212121, C2 and P1, respectively, at resolutions ranging from 1.8 Å to 3.5 Å (Table 1).
The combination of nine different geometries for individual connector modules results in 81 different geom-
etries for triple DARPin fusions. We only tested the nine “symmetric” D12_Hxx_D12_Hxx_D12 constructs, 
with the same connector geometries on either side of the central DARPin domain. D12_H06_D12_H06_D12 
crystallized in space group C2 and was refined at 2.3 Å resolution. D12_H12_D12_H12_D12 crystallized under 
several different conditions; three structures were determined in space groups P212121, P21, and P3221 at resolu-
tions between 2.4 Å and 2.6 Å. D12_H15_D12_H15_D12, the construct with the longest shared helices, crystal-
lized in space group P21 and the structure was refined at 2.4 Å resolution. Symmetric DDD constructs with D12 
domains and H02, H09, H10, H11, H13, and H14 connectors did not yield diffraction-quality crystals upon initial 
screening.
Figure 2. Geometry of the nine shared helix constructs. The relative orientation of the two DARPins in the DD 
constructs is defined as the pseudo-torsion angle between the centers of gravity (cog) of the internal repeats of 
the two DARPins around the axis of the connecting helix. The nine DD constructs (H01, H06, H09, H10, H11, 
H12, H13, H14 and H15) are shown with the N-terminus of the first DARPin to the left. The top view of each 
construct illustrates the relative domain orientation; the axis of the shared helix is perpendicular to the image 
plane. The bottom view is rotated by 90°, illustrating the length of the shared helix (shown as black arrow). 
Capping repeats and connector modules are colored white, internal repeats pale yellow. Randomized residues 
determining the specificity of each DARPin are highlighted in orange, the shared helix in pink and mutations 
introduced to stabilize the connector module in red. The last panel shows an overlay of all nine models, 
illustrating the range of conformation covered by the nine constructs.
www.nature.com/scientificreports/
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Comparing designs and experimental structures. Table 1 summarizes the crystal parameters, rela-
tive domain orientations and agreement between models and experimental structures, and Fig. 3 illustrates the 
agreement between the designed models and experimental structures. Crystallization conditions, refinement 
statistics, and additional details are listed in Supplementary Tables 1 to 4. Five out of nine DD structures showed 
good agreement between design and experimental crystal structure with root mean squares deviation (rmsds) of 
the Cα atoms below 2 Å (Table 1, Fig. 3). This confirms the design strategy and validates the concept of a shared 
helix as a rigid connector. Thus, we can use this information to predict the relative orientation of binding sites 
with sufficient accuracy for future functional studies of DD and DDD constructs. In only three out of fourteen 
structures, dominant crystal contacts, sometimes only under specific crystallization conditions (low pH) signif-
icantly perturbed the geometry of the connector module. These deviations are discussed in the Supplementary 
Experimental Procedures and in Supplementary Fig. 4, and we argue that the structure in solution at neutral pH 
is likely to be very close to the design.
The structure of D12_H12_D12_H12_D12 was determined in three different space groups (P212121, P21, and 
P3221), which gives an estimate of the impact of crystal lattice forces on the shape of the molecule. Rmsds between 
chemically identical D12_H12_D12_H12_D12 constructs vary between 1.6 and 2.9 Å. The rmsd for the compar-
ison between design and crystal structure of DDD constructs with H06, H12 and H15 ranges from 1.5 to 4.2 Å. 
Considering the elongated shape of the DDD molecules, which amplifies the effect of small deviations in the 
connector, they agree remarkably well with the designs. Differences can be attributed to crystal lattice forces in 
the different lattices, which are a consequence of different crystallization conditions.
Crystal structures of ligand-bound DD constructs. In a second series of DD constructs, the N-terminal 
DARPin D12 was replaced by off7, a high-affinity binder for MBP5, while the C-terminal D12 was replaced by 
3G124, recognizing GFP19. For crystallization trials, the ternary complexes of all nine DD fusions with MBP and 
GFP were purified by preparative size exclusion chromatography. Two DD constructs yielded crystals of the ter-
nary complex: off7:MBP_H10_3G124:GFP crystallized in space group C2 (3.1 Å resolution, 3 complexes/ asym-
metric unit (a.u.)) and off7:MBP_H11_3G124:GFP in space group P21212 (3.0 Å resolution). All three components 
of the complexes were well-resolved in the electron density maps. Constructs off7_H09_3G124 (crystallized at pH 
4.6) and off7_H12_3G124 (crystallized at pH 5.0) diffracted to 1.9 Å and 2.4 Å resolution, respectively. In these 
structures the ligands were lost from the complex at acidic crystallization conditions (Supplementary Table 1). 
The other five off7_Hxx_3G124 constructs (with xx equal 02, 06, 13, 14, 15) did not yield diffraction-quality crys-
tals. Crystallization of triple DARPin fusions with MBP and GFP ligands was not attempted.
In the complexes, the interactions between DARPins and target proteins were found to be very similar to the 
interactions seen in the absence of fusion partners (Fig. 4). This is an important observation, as this reassures 
that any conclusions derived from complexes of DD and DDD fusions will also be valid for individual DARPins. 
Therefore, the fusion strategy with the well crystallizing DARPin D12 can be used to generate structural informa-
tion of the unfused complex.
PDB ID Construct DARPins
Shared helix 
length Ligands
Space 
group mol/au Resolution
Angle 
design
Angle 
structure
rmsd to 
model
5LW2 DARPin D12 D12 — unliganded C2 2 1.8 Å
5LE3 D12_H02_D12 D12/D12 14 aa unliganded P21212 4 3.5 Å 158 160 1.4
5LE6 D12_H09_D12 D12/D12 21 aa unliganded P6122 6 1.8 Å −176 172 7.0
5LE4 D12_H11_D12 D12/D12 23 aa unliganded P212121 1 2.4 Å −18 −25 6.4
5LE7 D12_H13_D12 D12/D12 25 aa unliganded C2 4 2.1 Å 147 144 1.0
5LE8 D12_H15_D12 D12/D12 27 aa unliganded P1 2 1.8 Å 55 64 2.0
5LEB D12_H06_D12_H06_D12 D12/D12/D12 18 aa unliganded C2 1 2.3 Å 120 134/140 4.1
5LEC D12_H12_D12_H12_D12 D12/D12/D12 24 aa unliganded P212121 1 2.5 Å −113 −94/−113 4.2
5LED D12_H12_D12_H12_D12 D12/D12/D12 24 aa unliganded P21 1 2.6 Å −113 −110/−112 1.5
5LEE D12_H12_D12_H12_D12 D12/D12/D12 24 aa unliganded P3121 1 2.4 Å −113 −101/−103 2.8
5LE2 D12_H15_D12_H15_D12 D12/D12/D12 27 aa unliganded P21 2 2.4 Å 55 70/66 4.9
5LE9 off7_H09_3G124 off7/3G124 21 aa lost (pH 4.6) P41212 1 1.9 Å −176 128 6.0
5LEL off7:MBP_H10_3G124:GFP off7/3G124 22 aa MBP, GFP C2 3*3 3.1 Å 81 113 4.1
5LEM off7:MBP_H11_3G124:GFP off7/3G124 23 aa MBP, GFP P21212 1*3 3.0 Å −18 −18 1.7
5LEA off7_H12_3G124 off7/3G124 24 aa lost (pH 5.0) P21 1 2.4 Å −113 −114 1.0
Table 1. Overview over composition, crystal form, resolution, relative domain orientation, and agreement 
between design and experimental structures. Naming conventions are explained in Fig. 3. In case of complexes, 
the ligand name (e.g. MBP or GFP) is inserted right after the name of the cognate DARPin domain. A colon 
separates the DARPin domain from its ligand. The unfused DARPin D12 has been added as reference. “Angle” 
refers to the pseudo-torsion angle between the two DARPin domains, as defined in Fig. 2. For additional details, 
see Supplemental Tables ST1 (Crystallization conditions, data collection and refinement statistics) and ST2 to 
ST4 (comparison of models and structures).
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6Scientific RepoRts | 7: 11217  | DOI:10.1038/s41598-017-11472-x
Figure 3. Superposition of design and experimental structures. Models and experimental structures were 
superimposed by a least-squares fit of the Cα atoms of the three internal repeats of the first DARPin in the 
case of the two-DARPin constructs, or of the middle DARPin in the case of the three-DARPin constructs, 
with rmsds of 0.4 ± 0.03 Å. Models are shown in pale blue, experimental structures in red. Rmsd values for the 
superposition of the whole molecules are listed in Table 1, more details are given in Supplementary Tables 2 
to 4. DD constructs are named aaa_Hxx_bbb, where aaa and bbb are the abbreviated names of the N- and 
C-terminal DARPin domains, and Hxx indicates shared helix (with xx ranging from 02 to 15). DDD constructs 
are named aaa_Hxx_bbb_Hyy_ccc using the same scheme. In case of complex structures, the ligand name (e.g. 
MBP or GFP) is inserted right after the name of the cognate DARPin domain. The three independent crystal 
structures of construct D12_H12_D12_H12_D12 are distinguished by the space group of the crystals, P21, 
P212121 and P3221.
Figure 4. Ternary complexes of DD constructs with two different target proteins. (a) Structure of DARPin 
off7 in complex with maltose binding protein (MBP) (PDB entry 1SVX,5). (b) Ternary complex off7:MBP_
H10_3G124:GFP. (c) Ternary complex off7:MBP_H11_3G124:GFP. (d) Structure of DARPin 3G124:eGFP (S. 
Hansen, unpublished results). Structures a, b and c were superimposed by a least-squares fit of the off7 internal 
repeats. Structure d was superimposed on structure c by a least-squares fit of the 3G124 internal repeats.
www.nature.com/scientificreports/
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D12-mediated crystal contacts. The β-lactamase fusions with DARPin D1216 had shown that, while the 
paratope-paratope interactions of D12 are weak enough for constructs containing this DARPin to remain mon-
omeric during production and purification, they are strong enough to frequently form extended crystal contacts 
that have enabled crystallization under a wide variety of conditions. We therefore utilized D12 to facilitate crys-
tallization in this study and analyzed the crystal contacts formed by D12 and its fusion constructs. We wanted to 
elucidate the general features of a molecule such as D12 that has these favorable crystallization properties.
Indeed, in the majority of the D12-containing structures analyzed in this study, the D12 paratope-paratope 
interaction provided the largest crystal contact, with a total of around 1700 Å2 of solvent-accessible surface buried 
in the interface. Although the paratope-paratope interactions predominantly involve the second and third inter-
nal repeats and the adjacent C-cap of the DARPin units involved, the geometry of the interaction in the different 
structures falls in several distinct classes. For the sake of clarity, in Fig. 5 we show only the two DARPin moieties 
involved in the contact, aligned by one of the DARPins. The contribution of the individual interface residues to 
the total surface buried in the interface is shown as a color code on the opened-up interface. Supplementary Fig. 5 
offers a more detailed view of the residue interactions involved in interface formation.
Interface type I. In the crystal of unliganded DARPin D12 (details: Table 1), the paratope-paratope interaction is 
split into two interfaces (i.e., interacting with different molecules) of 498/473 A2 and 405/438 Å2 of surface buried, 
equivalent to 71% of all crystal contacts made by D12. The brown, green and red molecules shown in Fig. 5a and 
Supplementary Fig. 5a are related by a two-fold crystallographic screw axis. Additional interfaces are provided by 
capping repeats and by bridging Ca2+ ions. In the D12_H06_D12_H06_D12 crystal, both the N-terminal and the 
C-terminal DARPin units form similar paratope-paratope interfaces with two symmetry-related molecules each. 
To accommodate the capping repeats packing against the central DARPin, the inter-domain angle in this DDD 
construct widens from 120° in the model to 140° in the experimental structure.
Interface type II. The contacts shown in Fig. 5b are all within the asymmetric unit of D12_H09_D12. The 
observed pseudo-torsion angle of 172° is close to the predicted angle of −176°, but the connecting module is par-
tially disordered, such that the C-terminal DARPin is rotated 90° around its long axis. In this orientation, all four 
Figure 5. Dominant crystal contacts mediated by the D12 paratope. Symmetry-related molecules surrounding 
the asymmetric units of the different DD constructs were generated using the program PyMOL (www.pymol.
org) and crystal contacts were analyzed. Panels a–d show the five different classes of interfaces observed. Left, 
relative orientation of interacting DARPin(s) with respect to the green reference DARPin; arrows indicate the 
direction of the DARPins, from N-term to C-term. In panel d, cyan shows Type IV and dark blue shows type 
V. Right, per-residue surface accessibility of the isolated DARPin units and the pair forming a crystal contact 
were calculated using the program NACCESS (www.bioinf.manchester.ac.uk/naccess/), and from the difference 
the contribution of each residue to the interface was calculated and color-coded onto the Cβ atom represented 
as sphere (red: >100 Å2, orange-red: >80 Å2, orange: >60 Å2, yellow-orange. >40Å2, yellow: >20Å2, cream: 
>0 Å2, white: not involved in interface). The analysis is described in more detail Supplementary Experimental 
Procedures, and details of the interactions are presented in Supplementary Fig. 5a–e, a superposition of the five 
different relative orientations in Supplementary Fig. 5f.
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D12 units engage in paratope-paratope interactions, where two DARPin domains form an antiparallel dimer. Two 
such dimers pack into a barrel-like unit (Supplementary Figs 4a and 5b). The purple molecule in Fig. 5b shows the 
C-terminal DARPin packing against the green N-terminal DARPin, the pink molecule the N-terminal DARPin 
packing against the green C-terminal DARPin.
Interface type III. This is the most frequently observed paratope-paratope arrangement (Fig. 5c and 
Supplementary Fig. 5c). While the interface itself shows local two-fold symmetry, this interaction is also seen 
between non-symmetry-equivalent units, e.g. between the N-terminal and the C-terminal DARPin moiety 
of two symmetry-related molecules. In D12_H12_D12_H12_D12 (P3221), each of the three D12 paratopes is 
involved in an interaction of this type: The N-terminal DARPin interacts with the C-terminal DARPin of one 
symmetry-related molecule, the middle DARPin with the middle DARPin of a second one, and the C-terminal 
one with the N-terminal DARPin of a third symmetry mate. Similarly, in D12_H15_D12_H15_D12, the 
N-terminal DARPin interacts with the C-terminal DARPin of one symmetry-related molecule, the middle 
DARPin with the C-terminal DARPin of a second one, and the C-terminal DARPin with the middle DARPin of 
a third symmetry-related molecule. In D12_H12_D12_H12_D12 (P212121) only two of the three D12 domains 
are involved in paratope-paratope contacts, while the paratope of the C-terminal D12 domain contacts the 
backside of the middle D12 and the connector module and shared helix linking it to the C-terminal DARPin. 
D12_H15_D12 makes paratope-paratope contacts of this type both within the asymmetric unit and with 
symmetry-related molecules.
Interface type IV and type V. Two more types of paratope-paratope interactions with local two-fold sym-
metry are found that are similar to each other but differ from each other by the angle of interaction (Fig. 5d, 
Supplementary Fig. 5d,e). Type IV is found in D12_H02_D12 within the a.u., while contacts between molecules 
related by crystallographic symmetry are of type III. Type V (blue) contacts were not found in the molecules 
described here, but were found in fusions of D12 with beta-lactamase (DB_04_v3_D12; PDB ID: 5AQ7)16.
Only three of the D12 constructs did not rely on paratope-paratope interactions, but instead relied on 
paratope-capping repeat or paratope-connector module interactions as dominant crystal contacts: D12_
H11_D12, D12_H13_D12 and D12_H12_D12_H12_D12 (P21). Constructs containing the H14 connector mod-
ule failed to crystallize. Modeling showed that the most favored paratope-paratope contact of one DARPin would 
lead to clashes of the second DARPin for D12_H14_D12, offering a potential explanation for this observation.
In summary, DARPin D12 can form five predominant types of interaction with its paratope in arrangements 
with and without local symmetry, compatible with numerous crystal forms, involving both non-polar and charge 
interactions (Supplementary Fig. 5), while it shows no dimer formation in solution in any fusion protein under 
the conditions tested.
Discussion
In this paper, we present a strategy to fuse specific, high-affinity protein binders to obtain multivalent or multispe-
cific scaffolds of predetermined geometry. DARPins are used as building blocks to confer the desired specificity 
to the construct. A series of rigid connector modules replacing the DARPin capping repeats allow to combine the 
individual DARPin domains in such a way that their distance and angle can be altered to test different geometries, 
bringing the binding partners of the DARPins into a defined spatial arrangement. To test the accuracy of the 
design we determined the experimental structures of different bi- and trivalent constructs.
The key feature of the novel constructs presented in this study is the rigid yet adjustable connection between 
the DARPin moieties, which becomes possible through the shared helix design — a feature not achievable for 
most scaffolds. While the simplest way to recruit target proteins into multi-component complexes would be to 
fuse the target-binding domains by flexible linkers, this obvious strategy will fail to control the spatial orientation 
of targets, which in many cases is key for the molecular function of the complex. We chose to use α-helices as 
rigid linkers to connect the DARPin domains, because DARPins possess helices on their N- and C-terminal ends, 
allowing a tight integration of the connector into the fold of the target-binding domain. The two helices are not 
just joined end-to-end, but instead the two domains are made to overlap in such a way that the joining helix is 
stabilized by contacts with the domain cores along its entire length. As a result, the sequence of the joining helix 
and the contacting domains had to be adapted using the Rosetta software suite17.
In total, we designed and tested nine different connector geometries and confirmed the success of the designs 
by biochemical and biophysical methods. All DD and DDD constructs are well-behaved proteins that can be 
expressed at high yield from bacterial expression cultures, are monomeric even for binding domains with rela-
tively hydrophobic paratopes, and retain the target-binding affinities of the parental DARPins. Fourteen crystal 
structures of DD and DDD constructs, covering eight out of nine connector geometries, validate the accuracy of 
the design. Indeed, for most constructs, experimental crystal structures agree remarkably well with the designs 
(Table 1 and Fig. 3). A comparison of three structures of the same construct (D12_H12_D12_H12_D12), deter-
mined in different crystal lattices, shows that differences between the structures (rmsds up to 3 Å) are caused by 
crystal lattice forces. The deviations between different crystal forms are of the same magnitude as the deviations 
between structures and model. The structures of these DDD fusions are very extended in one direction (>110 Å 
from N- to C-terminus), and thus amplify the effects of small deviations in the inter-domain angles, making the 
agreement with the designs even more remarkable. For most DD and DDD constructs, the rmsds between design 
and experimentally determined structures are even lower, confirming the suitability of the design strategy. This 
validation is particularly important for the design of even larger DARPin-derived scaffold proteins and the inter-
pretation of the different biological effects of DARPins joined in different relative orientations. Within the con-
structs, the DARPins moieties always keep their intrinsic structure due to their high stability, and in the majority 
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of cases the shared helix stays intact. Only a few structures show a kinked, disordered or dissociated shared helix 
(e.g. D12_H09_D12), but even then the DARPins stay fully intact, demonstrating that local perturbations of the 
structure in the helix region can be accommodated without unfolding the DARPin moieties.
Crystallization of the constructs was facilitated by the discovery of a particular DARPin paratope that appears 
to frequently make versatile crystal contacts especially readily, opening the possibility of using these rigid 
multi-DARPin scaffolds to facilitate the crystallographic analysis of DARPin-target complexes that would not 
yield crystals otherwise. In the absence of its ligand, the interactions of DARPin D12 are weak enough for con-
structs containing this DARPin to remain monomeric during expression and purification. Upon crystallization, 
the paratope-paratope interactions of this DARPin are strong enough to form prominent crystal contacts under a 
wide variety of conditions (Fig. 5). This DARPin may thus be added to the portfolio of well crystallizing proteins 
such as, e.g., T4 lysozyme20, apo-cytochrome B(562)RIL and several others21, yet with the additional advantage 
of being able to be fused to other proteins in a rigid manner and be part of binding complexes. DARPin-target 
complexes that fail to crystallize can be expanded by rigidly fused D12 modules on either side of the DARPin of 
interest to provide additional crystal contacts. This approach enabled us to produce diffraction-quality crystals 
and thus understand the mode of action of two DARPins bound to their targets (Y. Wu et al., manuscript sub-
mitted), when all previous attempts to crystallize the DARPin-target complexes had failed. Since target-binding 
DARPins can now be rapidly generated from library selections6, and the capping repeats of each binder can then 
be replaced by a generic set of modular fusion constructs, this overall strategy can also be used to facilitate protein 
crystallization in general, and these fusions can be used as a next-generation crystallization chaperone.
The structures of off7:MBP_H10_3G124:GFP and off7:MBP_H11_3G124:GFP (Fig. 4) confirm that DD 
fusions are capable of crystallizing with two target proteins bound simultaneously. Modeling predicts that all nine 
DD constructs and 76 out of 81 DDD constructs should be able to bind two or three MBP-sized ligands simul-
taneously, respectively. The experimental structures elucidated in this study demonstrate this point: although all 
design steps were performed on models based on a single consensus DARPin not binding to any target (PDB ID: 
2XEE,22), the internal repeats of the individual DARPin units in the fusion constructs could be readily replaced 
and indeed recognized the cognate target in the expected manner.
The propensity of DARPin D12 to engage in crystal contacts is so large that, where the crystal geometry 
does not allow for its preferred interaction, alternative interaction geometries are observed. These are found as 
paratope-paratope interactions, interactions with the DARPin N- and C-caps, with connector modules or with 
the target protein of a second DARPin in the construct. Occasionally, the DARPin fusion constructs would rather 
distort the conformation of the connector module than forgo the formation of such favorable crystal contacts. 
Where we found deviations between design and experimental structures, the deviations can be explained either 
by crystal interactions and/or crystallization conditions.
The largest deviation was found for construct D12_H09_D12 (Supplementary Fig. 4a), where the loop and 
first helix of the connector module (residues 141–156) were disordered in order to accommodate the second 
DARPin to engage in paratope-paratope type II interactions, Fig. 5b). In order to form an antiparallel dimer in 
which both D12 moieties engage in this interaction, the second D12 moiety had to rotate along its long axis.
In the off7_H09_3G124 structure, residues 141–156 are clearly visible in the electron density map, but the 
angle between the last helix of the N-terminal DARPin domain and the H09 connector substantially differs from 
the design (Supplementary Fig. 4c). However, this construct crystallized at pH 4.6. DARPin repeats carry a con-
served TPLH motif in the first helix of the N-cap5, 23, and protonation of the histidine residues in this motif 
reduces stability and weakens the binding affinity of the DARPin moiety, leading to the loss of MBP and GFP 
from the ternary complex. Nonetheless, independent binding data at neutral pH strongly indicate that the con-
formation in solution must be closely similar to the design24.
In summary, the strategy of rigid protein fusions, by embedded shared helices, has been found to be a versatile 
and modular approach to design a range of rigid proteins of predetermined dimension and orientation. It has 
greatly increased the utility of DARPins as crystallization chaperones by extending the search space for crys-
tal formation through the dimensions of geometry, surface composition and orientation. This strategy should 
expand the toolbox for structure determination. However, potential applications of rigid DARPin-DARPin 
fusions go far beyond their utility as crystallization chaperones: these constructs can be used to organize supra-
molecular complexes of different geometries, and they can modulate the activity of target molecules not only by 
the direct effects of the DARPin moiety binding to its targets, but by bringing different targets together, forcing 
them into a specific relative orientation and modulating their conformation. The crystal structures presented in 
this article show the general validity of this strategy, and thus help the future design of supramolecular complexes 
based on DARPin-rigid helix scaffolds with various target proteins.
Materials and Methods
Design. PyMOL (www.pymol.org) was used for initial screening for non-clashing DARPin/helix/DARPin 
arrangements. InsightII (Accelrys, SanDiego) was used to stitch the fragments together into one continuous chain 
and to regularize the backbone at the splice sites. Rosetta fixbb17 was used for sequence optimization, and Rosetta 
relax to confirm that the backbone conformation remained stable upon energy minimization.
Protein expression, purification and characterization. Expression of DARPin-based fusion con-
structs and target proteins, including DD fusions, DDD fusions, MBP, and GFP were all carried out with plas-
mid pQE30ss (a pQE30-derived vector with double stop codon) containing an N-terminal MRGS-His6 tag, and 
produced in E. coli XL-1 Blue (see Supplementary Experimental Procedures for details). MBP and GFP were 
biotinylated at the avi tag in vivo by co-transfected plasmid pBirAcm in E. coli XL-1 Blue (Stratagene), according 
to the protocols of Avidity and QIAGEN.
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Proteins used for crystallization were purified by immobilized metal-ion affinity chromatography (IMAC). 
The elution buffer was exchanged to HBS150 (10 mM HEPES-Na, pH 7.4, 150 mM NaCl) on PD-10 desalt-
ing columns (GE Healthcare) according to the manufacturer’s instructions. Size exclusion chromatography 
was performed for further purification of complexes of DD constructs with their targets (MBP or GFP) (see 
Supplementary Experimental Procedures for details). To qualitatively assess whether DARPin-DARPin fusion 
constructs retain binding to their target(s), all expressed and purified DD fusion constructs were individually 
tested for binding to their target(s) by ELISA (see Supplementary Experimental Procedures for details).
Crystallization, data collection and processing. Crystallization was set up using a variety of screens 
available at the in-house protein crystallization center. The proteins were concentrated to 10–25 mg/ml and mixed 
with the mother liquor in a volume ratio of 1:1, 1:2 and 2:1 for each single condition. Grid screening optimization 
of crystallization conditions was done with sitting-drop crystallization plates from Hampton Research. Crystal 
growth took place at 20 °C. Crystals typically appeared within a week and grew to their maximum size within 2 
to 3 weeks. Crystallization conditions are summarized in Supplementary Table 1. Initial screens revealed that 
some of the DD fusion variants crystallized readily over a wide pH range. After optimization with custom-made 
focal grid screens, the best crystals were used in X-ray diffraction experiments. Diffraction data were collected 
at the Swiss Light Source, and the structures were determined by molecular replacement (See Supplementary 
Experimental Procedures for details).
Accession number. The atomic coordinates of DARPin D12, the DARPin–DARPin fusions and complexes 
with their cognate targets have been deposited in the PDB (PDB ID: 5LE2, 5LE3, 5LE4, 5LE6, 5LE7, 5LE8, 5LE9, 
5LEA, 5LEB, 5LEC, 5LED, 5LEE, 5LEL, 5LEM, 5LW2).
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